A man who worked at a Boston office of a global pharmaceutical company earned more than $250,000 in a stock market trade using non-public information.

AM(IST)on Wednesday in an upbeat market. Divi's Laboratories Ltd.(up 5.21 per cent), Sanofi India Ltd.(up 2.55 per cent), ...

Devonian Health Group Inc. (“Devonian” or the “Corporation”) (TSXv: GSD), a clinical stage botanical pharmaceutical corporation, focused on developing ...

As activist Starboard teams up with former Pfizer executives, the pharma giant’s lack of focus is in the spotlight.

Lenacapavir is already in use as a treatment for HIV. However, pharma giant Gilead has been testing it as an injectable form ...

The Pharma & Biotech market had a relatively positive month with 41.5% of the coverage universe posting positive share price ...

Forty years after the Hatch-Waxman Act created a market for affordable generic versions of prescription medications, ...

Jonathan Chang, an analyst from Leerink Partners, maintained the Buy rating on Vincerx Pharma Inc (VINC – Research Report). The ...

The bill, which was introduced July 23 in the House, is aimed at implementing a pharmacy reimbursement model to use national ...

A federal judge ordered the tech giant to let rival app stores onto its Android smartphone platform, adding to its growing ...

We recently compiled a list of the Seth Klarman Stock Portfolio: Top 10 Stock Picks. In this article, we are going to take a ...

Eli Lilly shares have soared thanks to excitement about the company's position in the weight loss drug market.